Articles dans des revues avec comité de lecture (66)
  1. 1. Eski, S. E., Mi, J., Pozo Morales, M., Hovhannisyan, G., Perazzolo, C., Manco, R., Ez-Zammoury, I., Barbhaya, D., Lefort, A., Libert, F., Marini, F., Gurzov, E. N., Andersson, O., & Singh, S. P. (2025). Cholangiocytes contribute to hepatocyte regeneration after partial liver injury during growth spurt in zebrafish. Nature communications, 16(1), 5260. doi:10.1038/s41467-025-60334-y
  2. 2. Vandenbempt, V., Roach, M., Mohenska, M., Wise, K., Wang, T., Harvey, K., Jensen, K., Swarbrick, A., Polo, J. M., Gurzov, E. N., & Martelotto, L. G. (2025). Validation of single-cell transcriptomic profiles from Illumina and MGI Tech sequencing platforms. FEBS letters. doi:10.1002/1873-3468.70087
  3. 3. Traini, L., Negueruela Escudero, J., Elvira Jimenez, B., St-Pierre-Wijckmans, W., Vandenbempt, V., Buss, C. E., Li, A., Perez Chavez, I., Ribeiro-Costa, F., Nunes, M., Messens, J., Ezeriņa, D., Hay, D. C., Bansal, M., & Gurzov, E. N. (2025). Genome editing of TXNIP in human pluripotent stem cells for the generation of hepatocyte-like cells and insulin-producing islet-like aggregates. Stem cell research & therapy, 16(1). doi:10.1186/s13287-025-04314-5
  4. 4. Perez Chavez, I., Baeyens, N., Ezeriņa, D., Gurzov, E. N., & Messens, J. (2025). Protocol for real-time glycolytic monitoring in mammalian cells using confocal microscopy and HYlight, a biosensor for fructose 1,6-bisphosphate. STAR Protocols, 6(2), 103792. doi:10.1016/j.xpro.2025.103792
  5. 5. Tillett, B. J., Dwiyanto, J., Secombe, K. K., George, T., Zhang, V., Anderson, D., Duggan, E., Giri, R., Loo, D., Stoll, T., Morrison, M., Begun, J., Hill, M. M., Gurzov, E. N., Bell, K. J., Saad, S., Barlow, C. C., Creek, D. D., Chong, C. W., Mariño, E., & Hamilton-Williams, E. E. (2025). SCFA biotherapy delays diabetes in humanized gnotobiotic mice by remodeling mucosal homeostasis and metabolome. Nature communications, 16(1), 2893. doi:10.1038/s41467-025-58319-y
  6. 6. Gilglioni, E. H., Bansal, M., St-Pierre-Wijckmans, W., Talamantes, S., Kasarinaite, A., Hay, D. C., & Gurzov, E. N. (2025). Therapeutic potential of stem cell-derived somatic cells to treat metabolic dysfunction-associated steatotic liver disease and diabetes. Obesity reviews, e13899. doi:10.1111/obr.13899
  7. 7. Pérez-Chávez, I., Koberstein, J. J., Pueyo, J. M., Gilglioni, E. H., Vertommen, D., Baeyens, N., Ezeriņa, D., Gurzov, E. N., & Messens, J. (2024). Tracking fructose 1,6-bisphosphate dynamics in liver cancer cells using a fluorescent biosensor. iScience, 27(12), 111336. doi:10.1016/j.isci.2024.111336
  8. 8. Gilglioni, E. H., Li, A., St-Pierre-Wijckmans, W., Shen, T.-K., Perez Chavez, I., Hovhannisyan, G., Lisjak, M., Negueruela Escudero, J., Vandenbempt, V., Bauzá-Martinez, J., Herranz, J. M., Ezeriņa, D., Demine, S., Feng, Z., Vignane, T., Otero Sanchez, L., Lambertucci, F., Prašnická, A., Devière, J., Hay, D. C., Encinar, J. A., Singh, S. P., Messens, J., Filipovic, M. R., Sharpe, H. J., Trepo, E., Wu, W., & Gurzov, E. N. (2024). PTPRK regulates glycolysis and de novo lipogenesis to promote hepatocyte metabolic reprogramming in obesity. Nature communications, 15(1), 9522. doi:10.1038/s41467-024-53733-0
  9. 9. Negueruela Escudero, J., Vandenbempt, V., Talamantes, S., Ribeiro-Costa, F., Nunes, M., Marques Dias, A., Bansal, M., & Gurzov, E. N. (2024). Protocol for CRISPR-Cas12a genome editing of protein tyrosine phosphatases in human pluripotent stem cells and functional β-like cell generation. STAR Protocols, 5(3), 103297. doi:10.1016/j.xpro.2024.103297
  10. 10. Vandenbempt, V., Eski, S. E., Brahma, M. K., Li, A., Negueruela Escudero, J., Bruggeman, Y., Demine, S., Xiao, P., Cardozo, A. K., Baeyens, N., Martelotto, L., Singh, S. P., Mariño, E., Gysemans, C., & Gurzov, E. N. (2023). HAMSAB diet ameliorates dysfunctional signaling in pancreatic islets in autoimmune diabetes. iScience, 27(1), 108694. doi:10.1016/j.isci.2023.108694
  11. 11. Talamantes, S., Lisjak, M., Gilglioni, E. H., Llamoza-Torres, C., Ramos-Molina, B., & Gurzov, E. N. (2023). Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma. JHEP Reports, 100811. doi:10.1016/j.jhepr.2023.100811
  12. 12. Takiishi, T., Xiao, P., Franchimont, M., Gilglioni, E. H., Arroba, E., Gurzov, E. N., Bertrand, M., & Cardozo, A. K. (2023). Inhibition of RIPK1 kinase does not affect diabetes development: β-Cells survive RIPK1 activation. Molecular metabolism, 69, 101681. doi:10.1016/j.molmet.2023.101681
    13. << Précédent 1 2 3 4 5 6 7 8 9 Suivant >>